Here is the paper. Where did it say that the tumor was removed totally? Did you see how tumor lysate was prepared? Did you see most of patients had metastasized cancer?
Tissue was obtained via percutaneous core needle biopsy and/or fine needle aspiration (n = 26) or surgical resection (n = 3).
The most fundamental benchmark to differentiate different types of DC vaccines is to check if the DCs can be pulsed with whatever investigators want to. Only NWBO has the technology. Why is it so hard for you to get the point? There is no dot-connecting on this one. It is the fact. Here in this paper, the DC vaccine pulsed with tumor lysate with KLH is the same as DCVax-L in terms of pulsing technology.
AI
